Biotech

All Articles

Rivus' stage 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...

Ovid standstills preclinical job, IV system after soticlestat fall short

.Ovid Rehab currently uncovered last month that it was trimming its own headcount as the firm browse...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has actually opened a $700 million R&ampD center in the Boston Seaport, improving its RNA...

Boundless Bio helps make 'small' layoffs 5 months after $100M IPO

.Only five months after safeguarding a $one hundred thousand IPO, Boundless Bio is actually currentl...

Halda's $126M is going to progress 'secure as well as get rid of' tumor medications

.The preliminary phases of oncology R&ampD may not be short of fascinating brand-new techniques, and...

Lykos 'disappointments' certainly not making known research transgressions with author

.Psychopharmacology has taken 3 articles concerning midstage scientific test data evaluating Lykos T...

Analysts examine Avidity's DMD gain, showing subtleties in data

.Avidity Biosciences satisfied clients along with phase 1/2 information in Duchenne muscle dystrophy...

Actinogen's cortisol blocker stops working stage 2 depression research

.Actinogen Medical's cortisol blocker has missed the main endpoint of a phase 2 research in anxiety,...

Bivictrix chooses going exclusive only way to take ADC in to center

.Antibody-drug conjugates (ADCs) have gone to the center of many a billion-dollar biobuck licensing ...

TPG leadings up funds to $580M for financial investments across life sciences

.Asset supervisor TPG, which has assisted biotechs such as Sionna Therapeutics as well as Santa Ana ...